How to Use amyloid beta in a Sentence

amyloid beta

noun

• The test measures blood levels of a protein called amyloid beta.
  — WIRED, 8 Aug. 2023
• Leqembi was approved on data from a mid-stage trial that showed the drug knocked out amyloid beta.
  — Laurie McGinley, Anchorage Daily News, 19 Jan. 2023
• As a person ages, amyloid beta tends to accumulate in the brain and can eventually form plaques, which are linked to Alzheimer’s disease.
  — WIRED, 8 Aug. 2023
• Those failures largely centered on a sticky protein called amyloid beta, which forms plaques in the brains of many people with the disease and was hypothesized to be its root cause.
  — Ryan Cross, BostonGlobe.com, 15 Feb. 2023
• New medications can also reverse amyloid beta plaque build-up in the brain, a marker of Alzheimer’s disease.
  — Kaitlin Sullivan, Health, 26 July 2023
• The drug, called donanemab, is the latest treatment to target amyloid beta, a protein that builds up in the brain and is a signature characteristic of Alzheimer’s disease.
  — Laurie McGinley, Anchorage Daily News, 4 May 2023
• How does vitamin D help? Vitamin D can help rid the brain of the amyloid beta protein, integral to the development of plaque in Alzheimer’s disease.
  — Alexa Mikhail, Fortune Well, 2 Mar. 2023
• Panel weighs risks of side effects The drug manufacturers cited studies that showed the drug cleared amyloid beta from the brains of study participants.
  — Ken Alltucker, USA TODAY, 9 June 2023
• Here's how to eat to live longer, new study says The study researchers found higher numbers of immune cells tightly surrounding amyloid beta plaques as well as other cells responsible for inflammation and cell and tissue death.
  — Sandee Lamotte, CNN, 24 Mar. 2023
• This study did not, however, find any associations between vitamin D levels in the brain and the presence of lewy bodies or amyloid beta build up that signal the development of lewy body dementia and Alzheimer’s respectively.
  — Alexa Mikhail, Fortune Well, 25 Dec. 2023
• Donanemab is an antibody that identifies and destroys amyloid beta proteins, excess abnormal proteins that bind together to create brain plaques.
  — Annalisa Merelli, Quartz, 3 May 2023
• The drug is a monoclonal antibody medication given by intravenous infusion that targets amyloid beta proteins in the brain.
  — Lauren J. Mapp, San Diego Union-Tribune, 9 June 2023

Last Updated: 26 Nov 2024